Profile
VRNA VRTX REGN ARGX ALNY SGEN
Company Name Verona Pharma plc Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. argenx SE Alnylam Pharmaceuticals, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $72.68B $122.53B $81.62B $50.22B $43.35B $43.15B
Employees 0.21K 6.10K 15.16K 1.60K 2.23K 3.26K
CEO David S. Zaccardelli Reshma Kewalramani Leonard S. Schleifer Timothy Van Hauwermeiren Yvonne L. Greenstreet David R. Epstein
Ratings
VRNA VRTX REGN ARGX ALNY SGEN
Quant Rating Score 1 4 4 4 3 3
Quant Rating Strong Sell Buy Buy Buy Neutral Neutral
Trading
VRNA VRTX REGN ARGX ALNY SGEN
Last Close $106.91 $434.02 $704.31 $929.61 $460.54 $228.74
High 52 $106.91 $513.76 $788 $929.61 $491.09 $228.74
Low 52 $37.86 $366.54 $482.92 $532.27 $224.58 $228.74
Price vs. 52 Week High 0 % -15.52 % -10.62 % 0 % -6.22 % 0 %
Price vs. 52 Week Low 182.38 % 18.41 % 45.84 % 74.65 % 105.07 % 0 %
Total Return
VRNA VRTX REGN ARGX ALNY SGEN
1 Month Return 0 % 4.13 % 21.84 % 10.19 % -4.39 % 0 %
3 Month Return 1.06 % 11.32 % 22.74 % 40.57 % 0.8 % 0 %
6 Month Return 49.92 % -1.06 % 18.51 % 64.35 % 61.42 % 0 %
9 Month Return 66.4 % -6.08 % 3.57 % 45.48 % 84.22 % 0 %
YTD Return 130.21 % 7.78 % -1.13 % 51.16 % 95.72 % 0 %
1 Year Return 180.68 % -3.12 % -5.41 % 61.8 % 96.59 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VRNA VRTX REGN ARGX ALNY SGEN
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -147.93 % 9.76 % 3.92 % 65.28 % 5.97 % -5.87 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
VRNA VRTX REGN ARGX ALNY SGEN
Asset Growth 53.91 % 7.41 % 10.71 % -1.21 %
Gross Profit Growth - 1.16 % 26.81 % 22.93 %
Revenue Growth - 0.99 % 22.97 % 24.65 %
Revenue 3 Year -15.89 % 20.64 % 147.1 % 91.56 %
Revenue 5 Year - 73.64 % 775.72 % 215.48 %
Revenue 10 Year - 285.02 % 2487.4 % 494.04 %
EBIT Growth -131.37 % 9.09 % 24.59 % -3.48 %
Net Income Growth -224.78 % 2.09 % 36.82 % 9.51 %
Net Income 3 Yeari Growth Per Share -148.34 % 6.32 % 69.73 % -763.59 %
Net Income 5 Yeari Growth Per Share 25.82 % 31.91 % 73.13 % -276.93 %
Net Income 10 Yeari Growth Per Share -35.51 % 680.22 % 55.09 % -624.16 %
Operating Income Growth -133.02 % -7.46 % 37.31 % 10.13 %
Operating Cash Flow Growth (CFG) -143.33 % - -107.98 % 9.07 %
Operating 3 Year CFG -170.73 % -100 % 98.8 % -147.99 %
Operating 5 Year CFG 54.81 % -100 % 97.44 % -195.86 %
Operating 10 Year CFG 40.15 % -100 % 97.08 % -2622.09 %
EPS Growth -214.81 % 5.31 % 38.07 % 10.81 %
EPS Diluted Growth -208.93 % 8.19 % 38.07 % 10.81 %
Book Value Per Share -22.82 % 32.88 % 129.75 % -9.83 %
Share Holder 3 Year Equity Growth Per Share 1.82 % 41.21 % -89.42 % 33.72 %
Share Holder 5 Year Equity Growth Per Share -24.45 % 191.63 % -96.01 % 220.81 %
Share Holder 10 Year Equity Growth Per Share -71.86 % 842.11 % -95.83 % 691.19 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 139.05 % 0.06 % 110.16 % -23.28 %
Free Cash Flow Growth -144.48 % - -201.54 % 3.67 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2022
Profitability
VRNA VRTX REGN ARGX ALNY SGEN
Gross Profit Margin TTM 95.15 % 86.28 % 86.27 % 65.82 % 83.99 % 79.1 %
Return on Assets TTM -11.01 % 14.78 % 11.11 % 15.06 % 0.9 % -16.61 %
Return on Equity TTM -30.05 % 21.81 % 14.83 % 18.96 % 26.13 % -20.8 %
Return on Capital Employed TTM -8.31 % 19.59 % 10.3 % 5.04 % 8.03 % -21.46 %
Net Income Per EBT TTM 111.64 % 82.61 % 86.12 % 237.3 % -136.38 % 101.33 %
EBT Per Ebit TTM 130.36 % 111.4 % 146.19 % 147.38 % -12.07 % 98.26 %
EBIT Per Revenue TTM -25.86 % 34.06 % 24.95 % 13.47 % 8.25 % -31.24 %
Cash Flow To Debt Ratio TTM -29.66 % 202.64 % 184 % 932.29 % 9.59 % -1043.73 %
Receivables Turnover TTM 1.93 6.02 2.5 1.91 3.33 3.91
Payables Turnover TTM 2.37 0.4 2.1 0.9 4.37 1.97
Inventory Turnover TTM 0.94 0.99 0.62 2.26 6.82 0.96
Fixed Asset Turnover TTM 6536.22 % 388.59 % 280.11 % 5009.77 % 463.12 % 665.41 %
Asset Turnover TTM 29.27 % 47.15 % 35.36 % 31.97 % 66.16 % 53.41 %
Operating Cash Flow Per Share TTM -0.85 14.55 48.39 5.67 2.02 -2.46
Free Cash Flow Per Share TTM -0.85 13.06 39.66 5.58 1.68 -2.88
Cash Per Share TTM 511.43 % 2459.7 % 8362.68 % 5536.58 % 2072.79 % 939.52 %
Operating Cash Flow Sales Ratio TTM -43.23 % 31.71 % 34.71 % 17.54 % 8.28 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.75 % 89.76 % 81.96 % 98.47 % 83.26 % 117.04 %
Cash Flow Coverage Ratios TTM -29.66 % 202.64 % 184 % 932.29 % 9.59 % -1043.73 %
Price To Free Cash Flows Ratio TTM -995.27 36.72 20 127.92 195.85 -81.26
Price To Operating Cash Flows Ratio TTM -126.33 32.86 16.23 144.41 162.25 -93.1
Price Cash Flow Ratio TTM -126.33 32.86 16.23 144.41 162.25 -93.1
Income Statement (TTM)
VRNA VRTX REGN ARGX ALNY SGEN
Revenue $0.03B $11.02B $14.34B $2.19B $2.25B $1.96B
Gross Profit $0.03B $9.49B $12.24B $1.96B $1.92B $1.55B
Gross Profit Ratio 93.89% 86.11% 85.35% 89.62% 85.62% 79.1%
EBITDA $-0.12B $0.49B $5.82B $0.11B $-0.18B $-0.62B
Net Income $-0.14B $-0.54B $4.5B $0.83B $-0.28B $-0.61B
EPS Diluted -1.73 -2.08 41.48 12.78 -2.18 -3.3
Balance Sheet (MRQ)
VRNA VRTX REGN ARGX ALNY SGEN
Long Term Debt $0.12B $1.66B $2.71B $0.03B $2.59B $0.04B
Total Liabilities $0.27B $6.12B $9.3B $0.7B $4.17B $0.87B
Total Equity $0.2B $16.41B $31.26B $5.5B $0.07B $2.8B
Total Investments $0.02B $6.65B $15.75B $1.93B $1.73B $1.42B
Total Debt $0.12B $1.75B $2.71B $0.04B $2.74B $0.04B
Total Assets $0.47B $22.53B $40.56B $6.2B $4.24B $3.67B
Cash Flow Statement (TTM)
VRNA VRTX REGN ARGX ALNY SGEN
Net Income $-0.17B $-0.54B $4.5B $0.83B $-0.28B $-0.61B
Inventory $-0.01B $-0.52B $-0.28B $-0.1B $0.01B $-0.23B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.12B $-0.49B $4.98B $-0.08B $-0.01B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.9B $-0.07B $-0.03B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.345
AARD Aardvark Therapeutics, Inc. Common Stock 12.27
ABCL AbCellera Biologics Inc. 2.94
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.995
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.395
ABPWW 0.0131
ABSI Absci Corporation 2.415
ABUS Arbutus Biopharma Corporation 4.01
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.35
ACAD ACADIA Pharmaceuticals Inc. 21.605
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.74
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.13
ACIU AC Immune SA 2.93
ETFs With Exposure to VRNA
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.56071 170.663
SPDW SPDR Portfolio Developed World ex-US ETF 0.025326 48.64
GWX SPDR S&P International Small Cap ETF 0.149582 45.32
BIB ProShares Ultra Nasdaq Biotechnology 0.533968 83.06
MNA IQ Merger Arbitrage ETF 3.06 36.235
ONEQ Fidelity Nasdaq Composite Index ETF 0.03 88.945
GURU Global X Guru Index ETF 1.19 60.925
FTLS First Trust Long/Short Equity ETF -0.19 70.82
AADR AdvisorShares Dorsey Wright ADR ETF 6.99 94.045
FPXI First Trust International Equity Opportunities ETF 0.000001 66.51
ISCF iShares MSCI Intl Small-Cap Multifactor ETF 0.07744 45.04
MRGR ProShares Merger ETF 2.38805 44.695
SBIO ALPS Medical Breakthroughs ETF 0.0633 50.155
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.000001 32.66
VINEX Vanguard International Explorer Fund Investor Shares 0.04069 22.17
VGHAX Vanguard Health Care Fund Admiral Shares 0.04 87.3
VGHCX Vanguard Health Care Fund Investor Shares 0.04 207.06
GINN Goldman Sachs Innovate Equity ETF 0.16 71.595
IBBQ Invesco Nasdaq Biotechnology ETF 0.82 29.13
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.81235 7.17
MMSC First Trust Multi-Manager Small Cap Opportunities ETF 0.35 24.79
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.81235 8.4975
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.8146 51.26
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.81235 8.451
DBXW.DE Xtrackers MSCI World Swap UCITS ETF 0.487907 120.44
XWEH.F Xtrackers MSCI World Swap UCITS ETF 0.487907 32.014
XSPU.L Xtrackers S&P 500 Swap UCITS ETF 0.261875 137.885
XWD1.F Xtrackers MSCI World Swap UCITS ETF 0.487907 16.5615
XS5E.DE Xtrackers S&P 500 Swap UCITS ETF 0.261875 10.1275
XSXD.L Xtrackers S&P 500 Swap UCITS ETF 0.261875 15.056
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.8146 60.83
MEDI Harbor Health Care ETF 0.00914799 30.62
XMWD.L Xtrackers MSCI World Swap UCITS ETF 0.487907 142.74
XS5G.L Xtrackers (IE) Public Limited Company - Xtrackers S&P 500 UCITS ETF 0.261875 12.754
D5BM.DE Xtrackers S&P 500 Swap UCITS ETF 0.261875 116.36
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.81235 6.235
XSPX.L Xtrackers - S&P 500 Swap UCITS ETF 0.261875 10121
XWEH.DE Xtrackers MSCI World Swap UCITS ETF 0.487907 48.333
JDOC JPMorgan Healthcare Leaders ETF 0.15 58.68
EHLS Even Herd Long Short ETF 0.64 25.325
FTKI First Trust Exchange-Traded Fun 0.000001 20.0099
Unlock